| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |